aspsirna0566 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0566
siRNA Name: SM2
Gene:Amyloid beta (A4) precursor protein(APP)
Disease:Alzheimers disease
Wild allele/target (5'->3'): AAGUGAAGAUGGAUGCAGAAU
Mutant allele/target (5'->3'):AAGUGAAUCUGGAUGCAGAAU
Target Mutation: c.2010_2011delGAinsTC (p.Lys670_Met671delinsAsnLeu)
Wild siRNA (As strand):UUCACUUCUACCUACGUCUUA
ASP-siRNA (As strand):UUCACUUAGACCUACGUCUUA
Mismatch position in siRNA: A8C,G9U
Mutant allele (5'->3'): AAGUGAAUCUGGAUGCAGAAU
ASP-siRNA (As strand):UUCACUUAGACCUACGUCUUA
ASP-siRNA efficacy for mutant allele:0
Wild allele (5'->3'): AAGUGAAGAUGGAUGCAGAAU
ASP-siRNA (As strand):UUCACUUAGACCUACGUCUUA
ASP-siRNA efficacy for wild allele:3
Percentage discrimination for ASP-siRNA:-3
Wild allele (5'->3'): AAGUGAAGAUGGAUGCAGAAU
Wild siRNA (As strand):UUCACUUCUACCUACGUCUUA
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): AAGUGAAGAUGGAUGCAGAAU
ASP-siRNA (As strand):UUCACUUAGACCUACGUCUUA
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:100pmol
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P56817
Target sequence: AAGUGAAGAUGG AUGCAGAAU
Genbank Accesion: NM_000484.3
Cell-line: CHO
Experimental technique used: RT-PCR
Transfection method: Lipofectamine 2000
siRNA expression method: Epicentre Technologies
Post-transfection duration: 48 hours
OMID ID: 104300
KEGG disease ID:H00056
Reference:16426772

.
.
.
.
.
.
.
.
.
.
.

.

.

.